HYALO
LIVE

Serial Number

79200241

Owner

Fidia Farmaceutici S.p.A.

Attorney

Andrew N. Fredbeck

Filing Date

Jul 29, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HYALO Trademark

Serial Number: 79200241 • Registration: 5499777

HYALO is a trademark filed by Fidia Farmaceutici S.p.A. on July 29, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Fidia Farmaceutici S.p.A.

Via Ponte della Fabbrica 3/A

Entity Type: 99

Trademark Details

Filing Date

July 29, 2016

Registration Date

June 26, 2018

Published for Opposition

April 10, 2018

Goods & Services

Pharmaceutical preparations for [ dermatological and ] gynecological use; [ pharmaceutical preparations for use during general, abdominal, gynecologic, cardiac, spine, tendon and peripheral nerve surgery; pharmaceutical preparations for the prevention of post-operative adhesions; dietary supplements for humans; plasters, materials for dressings; ] parapharmaceutical preparations for [ dermatological and ] gynecological use; anti-itch creams, gels [ and sprays ] for external use; antipruritics; [ lubricants for use with condoms; ] vaginal moisturizers; [ vaginal washes; ] personal sexual lubricants [ ; antiseptics; detergents for medical use; pomades for medical use; tissues or gauzes impregnated with antibacterial preparations, with medical creams or medical lotions for orthopedic and dermatological purposes, for wound healing and tissue repair; creams, sprays, lotions or gels for dermatological purposes, for wound healing and tissue repair; pharmaceutical preparations for the treatment of the mouth and teeth; minerals for medical use; vitamins; dietetic and nutritional supplements ]

[ Apparatus for medical imaging; surgical equipment for wound treatment; suture materials; medical devices for suture and wound closing; cutaneous, ophthalmic and intra-articular applicators for the administration of pharmaceutical preparations; applicators in the form of inhalers and injection devices for the administration of pharmaceutical preparations, namely, injection and infusion devices, needle-based and needle-free injection systems and syringes ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
May 14, 2026 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Mar 6, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 6, 2026 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 22, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 22, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jan 22, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2025 APRE
TEAS SECTION 71 RECEIVED
Jun 26, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 26, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 19, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 27, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 26, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 26, 2018 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 29, 2018 OPNX
REGISTERED-PRINCIPAL REGISTER
Jun 26, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 14, 2018 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 10, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 10, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Apr 6, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 21, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 21, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 21, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 7, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 7, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 7, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 7, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2018 TROA
ASSIGNED TO EXAMINER
Nov 27, 2017 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 23, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 23, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 23, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2017 TROA
REFUSAL PROCESSED BY IB
Feb 18, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 31, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 31, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 31, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 30, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 27, 2017 MAFR
ASSIGNED TO EXAMINER
Jan 23, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 19, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2017 REPR